Takeda’s CEO has said he is confident that its $62 billion acquisition of Shire will go ahead, despite a rebellion from a dissident group of shareholders.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,